Medical Grade Nitrous Oxide – various purity and package solution
Medical grade nitrous oxide has the ability to lower the mental consciousness of patients. This helps them tolerate pain and longer surgical processes.
Nitrous oxide is a clear, colorless, slightly sweet-smelling, non-irritating gas supplied in blue (ultramarine) cylinders as determined by AS4484.
For over 20 years, DSW has met the Nitrous Oxide requirements of its customers with quality that exceeds international specifications.
DSW helps meet an ever-increasing global need for Nitrous Oxide by offering various grades and package solutions directly to customers across Asia, Europe, South America, Australia, etc.
Cylinder sizes are available in 1.5L, 3.0L, 10L, 25L, 35L, and 50L as measured by nominal water capacity.
Nitrous oxide can be used as:
Fiber optics is used in the manufacture of optical fibers.
Rocket fuels are produced by oxidizing this component.
As an oxidizer for some types of analytical devices.
As an oxygen enrichment medium in high-performance internal combustion engine (drag racing).
In calibration mixtures for environment control.
As an oxygen source for the chemical vapor deposit of silicon oxynitride.
In various fields, nitrous oxide can be used in aerosol/propellants.
For whipped cream, syrups, coffee, chocolate, and other flavors, sauces to grill meats, vinaigrette etc.
Sprays of pharmaceuticals
in cosmetics (perfumes, eau de cologne, hair spray, etc.)
In household products, paints, varnishes, and insecticides,
Aerosols are used at low temperatures as deicers, starter boosters and other aerosols.
In the industry, nitrogen oxide is used as a leak detection agent for vacuum and pressure enclosures, underground piping, etc.
|Filling weight( N2O)
medical grade laughing gas
Purity 99.9% Medical Grade Nitrious Oxide Gas Medical Grade Colorless Appearance
CAS No.: 10102-43-9
EINECS No.: 233-271-0
UN No.: UN1660
Dot Class: 2.3
Grade Standard: Medical Grade
Medical grade nitrous oxide dosing information
Usual Pediatric Dose for Respiratory Failure:
Recommended dose: 20 ppm
Duration of therapy: 14 days or until the underlying oxygen desaturation has resolved
Weaning off: Down-titrate in several steps, pausing several hours at each step to monitor for hypoxemia
-Doses above 20 ppm are not recommended
-Avoid abrupt discontinuation
Use(s): To improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near term (over 34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents